Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection

10.1038/373123a0

10.1126/science.7824947

10.1056/NEJM199610103351501

10.1016/S0140-6736(96)05387-1

Bartlett JA, 1996, Ann Intern Med, 125, 161, 10.7326/0003-4819-125-3-199608010-00001

10.1056/NEJM199709113371101

10.1126/science.272.5265.1124

Hughes MD, 1997, Ann Intern Med, 126, 929, 10.7326/0003-4819-126-12-199706150-00001

O'Brien WA, 1997, Ann Intern Med, 126, 939, 10.7326/0003-4819-126-12-199706150-00002

10.1056/NEJM199602153340703

10.1126/science.272.5265.1167

Mellors JW, 1997, Ann Intern Med, 126, 946, 10.7326/0003-4819-126-12-199706150-00003

10.1038/nm0696-625

10.1056/NEJM199610103351502

1997, MMWR Morb Mortal Wkly Rep, 46, 165

Chaisson MA, Berenson L, Li W, Schwartz S, Mojica B, Hamburg M. Declining AIDS mortality in New York City (NYC). In: Program and abstracts of the Fourth Conference on Retroviruses and Opportunistic Infections, Washington, D.C., January 22–26, 1997. Washington, D.C.: IDSA Foundation for Retrovirology and Human Health, 1997:133. abstract.

Mouton Y, Cartier F, Dellamonica P, et al. Dramatic cut in AIDS defining events and hospitalization for patients under protease inhibitors (P.I) and tritherapies (TTT) in 9 AIDS référence centers (ARC) and 7,391 patients. In: Program and abstracts of the Fourth Conference on Retroviruses and Opportunistic Infections, Washington, D.C., January 22–26, 1997. Washington, D.C.: IDSA Foundation for Retrovirology and Human Health, 1997:208. abstract.

10.1056/NEJM199705223362118

10.1016/S0140-6736(05)62505-6

10.1056/NEJM199603143341106

10.1001/archinte.154.13.1497

10.1001/jama.276.2.146

D'Aquila RT, 1996, Ann Intern Med, 124, 1019, 10.7326/0003-4819-124-12-199606150-00001

10.1016/S0140-6736(94)90006-X

10.1001/jama.277.24.1962